ETHAN MYERS: Open Payments
NPI 1851952675 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,667 in 93 payments from 21 companies in 2025. Trend: 2023 $1,858 · 2024 $2,758 · 2025 $1,667
Food & beverage: $1,667
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $411 |
| PFIZER INC. | 13 | $205 |
| Amgen Inc. | 13 | $171 |
| AstraZeneca Pharmaceuticals LP | 8 | $151 |
| Gilead Sciences, Inc. | 5 | $109 |
| Lilly USA, LLC | 5 | $83 |
| Braeburn Inc. | 4 | $77 |
| Lundbeck LLC | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $53 |
| Janssen Pharmaceuticals, Inc | 2 | $52 |
Products named: VRAYLAR, NURTEC ODT, REXULTI, OTEZLA, BRIXADI, ELIQUIS, QULIPTA, MOUNJARO.
Industry payments across NY — which companies pay providers there.
